在臺灣放射腫瘤學會理事陳裕仁醫師的戮力協助下，雙方簽約儀式，由AME出版社汪道遠社長及臺灣放射腫瘤學會理事長，同時也是中國醫藥大學副校長的趙坤山教授代表出席，該簽約儀式亦邀請到AME旗下TCR期刊主編Prof. Eric Y. Chuang出席，一同見證這一刻。這是AME進軍臺灣的第一場戰役，可謂是AME獲得國際組織認可的又一新里程碑，亦是臺灣放射腫瘤學會為積極提高學術影響力而跨出的一大步。
圖1. 左起馬偕醫院陳裕仁主任、中國醫藥大學趙坤山副校長（學會理事長）、AME汪道遠社長、TCR主編Prof. Eric Y. Chuang
AME與臺灣放射腫瘤學會的此次「聯姻」，源自於TCR期刊主編Prof. Eric Y. Chuang的引薦。雙方在年初會面時便已播下合作的種子，在短期間內形成共識，加速了這本期刊的誕生。因此，AME與臺灣放射腫瘤學會於2017年中正式決定攜手合作，由具有豐富出版專業醫學期刊經驗的AME出版社，為該學會注入新血，在雙方合作下，互蒙其利，齊心將眼光及野心擴充套件至全球。我們期許這本期刊，對外，能夠有效提高腫瘤和相關疾病之放射治療及相關診療與學術研究水準；對內，可以藉由這個學術平臺，增進交流切磋的機會，繼而強化學會會員與國內外有關學術團體、學者之交流與合作力道。
The Collaboration between AME Publishing Company and Taiwan Society for Therapeutic Radiology and Oncology (TASTRO)
‘AME Publishing Company’ (AME) and ‘Taiwan Society for Therapeutic Radiology and Oncology’ (TASTRO) officially signed a contract on July 18th, 2017, laying down their cooperation in co-publishing a journal in the near future.
With the help of Prof. Yu-Jen Chen, the Director of TASTRO, the contract was signed by Mr. Stephen D. Wang, Founder and Chief Executive Officer of AME and Dr. Kun-Shan Zhao, the President of TASTRO and Vice President of China Medical University. Prof. Eric Y. Chuang, the Chief Editor of Translational Cancer Research (TCR), was also invited to witness this historical moment. This is the first time AME Publishing Company has burst into Taiwan’s market, and it is also a milestone for AME to be recognized by more international institutions. Signing this contract also allows TASTRO to increase its academic impact.
The collaboration is a result of the recommendation from Prof. Eric Y. Chuang. As a matter of fact, the seed of cooperation between the two parties were sowed at the beginning of the year. Reaching a consensus in a short period of time, it is expected that the journal will be published in the foreseeable future. AME Publishing Company, with considerable experience in publishing medical journals, will help bring vigor into Taiwan Society for Therapeutic Radiology and Oncology. Through the collaboration, both parties wish to mutually benefit each other and expand their influence to the globe. Not only do we hope this journal can enhance the academic level of Therapeutic Radiology and Oncology, but also foster communications among academic groups and scholars locally and internationally.
Introduction of AME Publishing Company
AME Publishing Company was established in July, 2009. (AME stands for Academic Made Easy, Excellent and Enthusiastic; the Chinese translation is 欲窮千里目，快樂搞學術; URL: www.amegroups.com) It is a start-up company aiming at scientific research with its primary core value ‘patients come first!’ Over the years, AME has published more than 40 medical journals, including the Journal of Thoracic Disease (JTD), Translational Cancer Research (TCR) and Hepatobiliary Surgery and Nutrition (HBSN), et al. So far, three AME journals have been indexed in SCI, and eighteen of them have been included in PubMed. AME has also hosted over 100 academic meetings in various forms.
Introduction of Taiwan Society for Therapeutic Radiology and Oncology
Taiwan Society for Therapeutic Radiology and Oncology was established over 2 decades ago. As the top institution in its profession, TASTRO has recruited numerous doctors studying Therapeutic Radiology and Oncology. Every year, it holds academic talks and seminars, and publishes academic papers and publications about Therapeutic Radiology and Oncology. Prior to cooperating with AME Publishing Company, TASTRO has already published the THERAPEUTIC RADIOLOGY AND ONCOLOGY, which accepts both Chinese and English manuscripts in the fields of Radiation Oncology, Radiation Biology, Health Physics, Radiation Physics and other Oncology-related disciplines.